Leif Bengtsson

Statistics

Publications

Citations

4.2K

H-Index

Active since

1978

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Cornell University

Goethe University Frankfurt

The Royal Free Hospital

University College London

Leif Bengtsson is an author at Vertex Pharmaceuticals (United States) specializing in pharmacotherapy, antiviral therapy, and hepatitis pharmacotherapy.

Publications per year

1978–2018

Publications

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection

Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2009 · 1K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor

Leona Bessonova, Nataliya Volkova, Mark Higgins et al. · Thorax · 2018 · 213 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

1369 TELAPREVIR SUBSTANTIALLY IMPROVED SVR RATES ACROSS ALL IL28B GENOTYPES IN THE ADVANCE TRIAL

Ira M. Jacobson, Ian M. Catlett, Patrick Marcellin et al. · Journal of Hepatology · 2011 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +4

P70 Telaprevir in combination with peginterferon and ribavirin in genotype 1 HCV Treatment-Naïve patients: final results of phase 3 ADVANCE Study: Abstract P70 Table 1

Geoffrey Dusheiko, Leif Bengtsson, Nathalie Adda et al. · Gut · 2011 · 66 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–5 of 20